Market closedNon-fractional
CorMedix/CRMD
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About CorMedix
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets.
Ticker
CRMD
Sector
Healthcare
Trading on
NASDAQ
Industry
Pharmaceuticals
Headquarters
Berkeley Heights, United States
Employees
83
Website
www.cormedix.com
CorMedix Metrics
BasicAdvanced
$259M
Market cap
-
P/E ratio
-$0.93
EPS
1.79
Beta
-
Dividend rate
Price and volume
Market cap
$259M
Beta
1.79
Financial strength
Current ratio
6.651
Quick ratio
6.141
Long term debt to equity
0.822
Total debt to equity
1.088
Interest coverage (TTM)
-1,238.24%
Management effectiveness
Return on assets (TTM)
-53.68%
Return on equity (TTM)
-89.76%
Valuation
Price to book
4.46
Price to tangible book (TTM)
4.62
Price to free cash flow (TTM)
-5.592
Growth
Earnings per share change (TTM)
15.76%
3-year earnings per share growth (CAGR)
6.76%
What the Analysts think about CorMedix
Analyst Ratings
Majority rating from 4 analysts.
CorMedix Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$0
NaN%
Net income
-$14M
-2.04%
Profit margin
0.00%
NaN%
CorMedix Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.25
-$0.17
-$0.26
-$0.25
-
Expected
-$0.24
-$0.21
-$0.20
-$0.28
-$0.25
Surprise
3.59%
-18.17%
28.87%
-9.91%
-
CorMedix News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for CorMedix stock?
CorMedix (CRMD) has a market cap of $259M as of July 27, 2024.
What is the P/E ratio for CorMedix stock?
The price to earnings (P/E) ratio for CorMedix (CRMD) stock is 0 as of July 27, 2024.
Does CorMedix stock pay dividends?
No, CorMedix (CRMD) stock does not pay dividends to its shareholders as of July 27, 2024.
When is the next CorMedix dividend payment date?
CorMedix (CRMD) stock does not pay dividends to its shareholders.
What is the beta indicator for CorMedix?
CorMedix (CRMD) has a beta rating of 1.79. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.
Buy or sell CorMedix stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.